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Summary Cognitive impairment is highly prevalent 
among the elderly. Subjects with disturbed glucose 
metabolism may be at risk of impaired cognitive 
function, as these disturbances can influence cogni- 
tion through atherosclerosis, thrombosis and hyper- 
tension. We therefore studied the cross-sectional s- 
sociation of cognitive function with hyperinsulin- 
aemia, impaired glucose tolerance and diabetes mel- 
litus in a population-based cohort of 462 men aged 
69 to 89 years. Cognitive function was measured by 
the 30-point Mini-Mental State Examination. Re- 
sults were expressed as the rate ratio (95 % confi- 
dence interval) of the number of erroneous answers 
given on the Mini-Mental State Examination by the 
index compared to the reference group. Compared 
to subjects with normal glucose tolerance, known dia- 
betic patients had a rate ratio of 1.23 (1.04-1.46), 
newly-diagnosed diabetic patients of 1.16 (0.91-1.48) 
and subjects with impaired glucose tolerance of 1.18 
(0.98-1.41), after adjustment for confounding due 
to age, occupation and cigarette smoking (p- 
trend = 0.01). Non-diabetic subjects in the highest 
compared to the lowest quartile of the area under 
the insulin curve had a rate ratio of 1.24 (1.03-1.50), 
after adjustment for confounding (p-trend = 0.02). 
The results did not change appreciably when poten- 
tially mediating factors, including cardiovascular dis- 
eases and risk factors associated with the insulin re- 
sistance syndrome, were taken into account. These 
results uggest that diabetes, as well as impaired glu- 
cose tolerance and hyperinsulinaemia in non-dia- 
betic subjects are associated with cognitive impair- 
ment. [Diabetologia (1995) 38: 1096-1102] 
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Cognitive impairment is an important component of 
dementia, and a major determinant of the quality of 
life. It is important to identify risk factors for cogni- 
tive impairment hat are potentially modifiable. 
There is now substantial evidence that in addition to 
diabetes mellitus, impaired glucose tolerance and hy- 
perinsulinaemia are also associated with atheroscle- 
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rosis, thrombosis, and abnormal haemodynamic pro- 
cesses [1--4]. All these processes may have an aetio- 
logic role in stroke and lacunar infarcts, which can 
subsequently ead to cognitive impairment and de- 
mentia. In addition, they are risk factors for white 
matter changes as seen on neuroimaging, which are 
associated with cognitive impairment [5]. 
Several clinical studies upport he hypothesis that 
diabetes and hyperglycaemia may be related to re- 
duced cognitive function [6-8]. However, little is 
known about the role of insulin in processes that 
may influence cognitive function. One study sug- 
gested, that among hypertensive patients, hyperinsu- 
linaemia increased the risk of cognitive impairment 
[9]. To our knowledge, no community-based studies 
have examined the relationship of cognitive function 
to diabetes, impaired glucose tolerance and hyperin- 
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su l inaemia .  There fore ,  we examined these  re la t ion -  
ships w i th  data  f rom the  Zutphen E lder ly  S tudy  [1]. 
In  add i t ion  we also assessed  the  ro le  of  poss ib le  med i -  
ators  of  this re la t ionsh ip ,  inc lud ing  card iovascu lar  
d i sease  and  r isk factors  assoc ia ted  w i th  the  insu l in  re-  
s is tance syndrome.  
Subjects and methods 
Subjects. The Zutphen Elderly Study is a longitudinal study of 
risk factors for chronic diseases in men. It is a continuation of 
the Zutphen Study, which was initiated in 1960 as the Dutch 
contribution to the Seven Countries Study [10]. Zutphen is a 
small industrial town located in the eastern part of the Nether- 
lands. Of the targeted 1266 men, 555 of whom were from the 
original cohort, born between 1900 and 1920, and 711 of 
whom were randomly selected from all other men in the same 
age range living in Zutphen, 939 participated in 1985. In the 
Spring of 1990, 544 of 718 (76 %) surviving men were re-exam- 
ined. Complete information on risk factors was available for 
462 men in 1990, who formed the sample for the present 
cross-sectional analysis. 
Examinations. An oral glucose tolerance test was performed 
according to World Health Organization (WHO) guidelines 
[11] in subjects without known diabetes. In the morning, after 
an overnight fast, a blood sample was obtained and then a glu- 
cose load of 75 g given. Blood samples were again taken after 1 
and 2 h. Fasting lucose concentration was determined for sub- 
jects known to have diabetes mellitus. Samples were collected 
in tubes with sodium fluoride. Plasma glucose was determined 
with the hexokinase method. Serum insulin was measured 
with a radioimmune assay (Pharmacia Diagnostics, Uppsala, 
Sweden). Within- and between-run coefficients of variation 
ranged from 6 to 7 %. The men were classified into three 
groups of glucose tolerance using the WHO criteria for diabe- 
tes and impaired glucose tolerance [11]. Diabetes was defined 
as a fasting glucose concentration over 7.8 mmol/1 or 2-h post- 
load glucose concentration over 11.1 mmol/1. Impaired glu- 
cose tolerance was defined as a fasting glucose concentration 
below 7.8 mmol/1 and a 2-h post-load concentration between 
7.8 and 11.1 mmol/1. Normal glucose tolerance was defined as 
both concentrations below 7.8 mmol/1. In addition, a fourth 
group of known diabetic subjects was created on the basis of 
the medical interview, independent of their fasting glucose 
measure. This group included subjects who were treated with 
insulin, oral hypoglycaemic agents and diet. The area under 
the post-load glucose and the insulin curve was calculated 
with the trapezoidal rule ((fasting concentration*30 rain) + (1- 
h concentration*60 rain) + (2-h concentration*30 min)). The 
area trader the insulin curve correlated most strongly with 1-h 
post-load insulin concentration (l-h: r = 0.97, 2-h: r = 0.71, fast- 
ing: r = 0.71). 
Global cognitive function was tested with the Dutch version 
of the 30-point Mini-Mental State Examination (MMSE) [12]. 
The MMSE includes questions on orientation to time and 
place, registration, attention and calculation, recall, language 
and visual construction. Although this screening test was origi- 
nally created for a clinical setting, it is extensively used in epi- 
demio!ogical studies, and has proven to be a reliable and valid 
indicator of cognitive impairment [13, 14]. It was administered 
by two trained nurses in a controlled hospital setting. If the 
subject did not answer fewer than four individual items (25 % 
of the questions) these were rated as errors (n = 22) [15], ex- 
cept for items which could not be performed because of physi- 
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cal disability, in which case a weighted total score was given 
(n = 10). If a subject did not answer four or more individual 
items the total MMSE score was considered missing (n = 5). 
We used a score of 26 or more as cut-off point for unimpaired 
cognitive function, since cognitive impairment is not very like- 
ly above this point. We used a score of 23 or less as an indicator 
of poor cognitive function, since this cut-off point has been 
shown to be indicative of dementia [14]. A score of either 24 
or 25 was called borderline cognitive function. 
Cardiovascular risk factors were obtained from a physical 
examination and a questionnaire, carried out by trained physi- 
cians. Body mass index (weight/height z) was calculated from 
height, measured to the nearest mm and body weight, re- 
corded to the nearest 0.5 kg while the men were in underwear. 
Systolic and diastolic (fifth Korotkoff phase) blood pressure 
were measured with a random zero sphygmomanometer in du- 
plicate on the right arm with the subject in supine position. The 
mean of the two blood pressure values was used in the analyses. 
Hypertension was defined as a systolic blood pressure greater 
than or equal to 160 mmHg or a diastolic blood pressure great- 
er than or equal to 95 mmHg or the use of anti-hypertensive 
medication, regardless of blood pressure level [16]. 
Fasting and non-fasting blood was obtained to determine 
the concentrations of lipoproteins and haemostatic factors. 
Non-fasting serum HDL cholesterol was determined enzymat- 
ically after precipitation of apo lipoprotein B containing parti- 
cles by dextran sulphate-Mg 2+ [17] by the standardized Lipid 
Laboratory at the Department of Human Nutrition, Wagenin- 
gen Agricultural University, The Netherlands. Fasting triglyc- 
eride was determined enzymatically b  the same laboratory us- 
ing a test kit (Boehringer Mannheim, Mannheim, Germany-) 
[18]. Fibrinogen concentration was determined by the method 
of Clauss [19], in which the clotting time is measured in a solu- 
tion of thrombin kept at constantly high concentration, added 
to diluted plasma. A standard curve is used to read the concen- 
tration of fibrinogen. Analyses were carried out at the Labora- 
tory of the Department of Human Biology, University of Lim- 
burg, Maastricht, The Netherlands. 
History of myocardial infarction, angina pectoris and inter- 
mittent claudication was obtained from the Dutch translation 
of a questionnaire developed at the London School of Hy- 
giene and Tropical Medicine [20]. A standardized history of 
stroke, transient ischaemic attack and diabetes was also ob- 
tained. Medical records on all subjects, including ECGs, hospi- 
tal discharge data and written information from general practi- 
tioners, were collected to verify diagnoses. Occupation was 
used as an indicator of intellectual capacity in this elderly 
Dutch population, that had had a reduced access to educa- 
tion. Lifetime occupation was obtained from a self-adminis- 
tered questionnaire, and coded from class one (professionals, 
managers and teachers) to class four (manual workers). Fi- 
nally, smoking habits were assessed by the physician, on the ba- 
sis of a standardized questionnaire. 
Statistical analysis 
Non-parametric tests (Kruskall-Wallis) were used to compare 
continuous kewed variables and chi-square tests to compare 
categorical variables. The number of erroneous answers on 
the MMSE, defined as 30 minus the MMSE score, followed a 
Poisson distribution. Therefore, multiple Poisson regression 
was used to estimate the rate ratio (RR) of the number of erro- 
neous answers on the MMSE in the index vs the reference 
group. Thus, a rate ratio of 1.29 indicates that the number of er- 
roneous answers on the MMSE in that group is on average 
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Table 1. Selected characteristics of elderly men by level of cognitive function: the Zutphen Elderly Study, 1990 
Characteristics Cognitive function 
Poor Borderline Unimpaired All 
MMSE score _< 23 MMSE score 24-25 MMSE score _> 26 (n = 462) 
(n = 74) 9 (n = 76) (n = 312) 
Age (years) 77.5 + 4.8 a 75.1 + 4.7 74.4 _+ 4.3 75.0 + 4.6 
Manual occupation (%) 36 b 26 21 25 
Current cigarette smokers (%) 26 22 21 22 
BMI (kg/m 2) 25.6 _+ 3.6 25.8 + 2.6 25.5 + 3.0 25.6 + 3.1 
HDL cholesterol (mmo]/1) 1.11 _+ 0.28 1.14 + 0.27 1.17 + 0.30 1.15 + 0.30 
Triglycerides (mmol/l) 1.38 _+ 0.70 1.52 + 0.82 1.44 + 0.76 1.44 + 0.76 
Fibrinogen (g/l) 3.75 -+ 0.34 3.72 + 0.28 3.68 + 0.33 3.69 + 0.32 
Presence of (%): 
Stroke 5 4 4 4 
Transient ischaemic attack 5 5 7 6 
Myocardial infarction 14 13 14 14 
Angina pectoris 20 14 13 15 
Intermittent claudication 8 14 9 10 
Hypertension 34 42 41 40 
Data given as mean + SD. a Overall chi-square test, p N 0.0001; b overall chi-square test, p _< 0.001 
29 % higher than in the reference group. Because of extra Pois- 
son variation, the standard errors of the estimated betas were 
computed using the robust (i. e. independent ofthe Poisson as- 
sumption) method escribed by Royall [21], and used to calcu- 
late the 95 % confidence intervals (CI). The SAS computer 
program version 6.09 was used [22]. 
To examine the relationship between glucose tolerance and 
cognitive function, we categorized subjects into normal and 
impaired glucose tolerance, and newly-diagnosed and known 
diabetes; according to the WHO categories. For the analyses 
on insulin, subjects were categorized into quartiles of the area 
under the insulin curve, after excluding known and newly-diag- 
nosed diabetic patients, because insulin concentrations u ually 
decline when a subject develops diabetes, which makes insulin 
levels difficult to interpret. Age, occupation, and cigarette 
smoking (current: yes/no) were added to the model to adjust 
for potential confounding. We examined whether the associa- 
tion changed after adjusting for possible mediating factors: 
those associated with the insulin resistance syndrome (Body 
Mass Index, hypertension, HDL cholesterol, triglycerides, fi-
brinogen), and cardiovascular diseases, including stroke, tran- 
sient ischaemic attack, myocardial infarction, angina pectoris 
and intermittent claudication. To examine whether glucose tol- 
erance and insulin were independently related to cognitive 
function, we also adjusted for fasting insulin in the analysis on 
glucose tolerance, and for glucose tolerance in the analysis on 
hyperinsulinaemia. We also performed a joint analysis in 
which the 2-h glucose and the area under the insulin curve 
were both added to one model as continuous variables. As 
with the other analysis on hyperinsulinaemia, these analyses 
exclude known and newly-diagnosed subjects. Interactions be- 
tween age and insulin or glucose concentrations, and between 
insulin and glucose concentrations, were investigated by in- 
cluding interaction terms in the models. All p-values are based 
on two-sided tests of statistical significance. 
Results 
The participants were aged 69 to 89 years, with a 
mean + SD age of 75 _+ 4.6 years. The median MMSE 
score was 26. Sixteen percent had a poor  cognitive 
function (MMSE score < 23), and 31% had a MMSE 
score of 24 or 25, indicating borderl ine cognitive per- 
formance. The subjects with the lowest scores were 
older and belonged more frequently to the manual  
occupat ion group (Table 1). Other  characteristics 
were not significantly different across levels of cogni- 
tive function. 
Cognitive function in diabetes mellitus and impaired 
glucose tolerance. Of the 37 known diabetic patients 
with complete information on risk factors, 8 were in- 
sulin treated. The subjects with impaired glucose tol- 
erance were older than the other subjects (Table 2). 
Occupational  history did not vary significantly by 
level of glucose tolerance. As expected, the mean 
area under  the insulin curve was highest in the sub- 
jects with impaired glucose tolerance and lowest in 
the subjects with normal  glucose tolerance. How-  
ever, the correlat ion between the area under  the in- 
sulin curve and 2-h glucose concentrat ion i non-dia- 
betic subjects was low (r = 0.19, p < 0.001). Stroke 
was considerably more f requent in subjects with im- 
paired glucose tolerance. The prevalence of poor  
cognitive function (MMSE score < 23) was highest 
in subjects with impaired glucose tolerance. After  
correct ion for confounding factors, including age, 
the number  of erroneous answers on the MMSE in- 
creased with increasing lucose intolerance level (p- 
t rend=0.01)  (Table2).  Known diabetic subjects 
made 23 % more errors in the MMSE,  newly-diag- 
nosed diabetic subjects 16 %, and subjects with im- 
paired glucose tolerance 18 %, compared with sub- 
jects with normal  glucose tolerance. The results did 
not change when potential ly mediating factors such 
as stroke, other cardiovascular diseases and vari- 
ables associated with the insulin resistance syn- 
drome, were taken into account. There were no sig- 
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Table 2. Selected characteristics and RRs (95 % confidence interval) of the number of incorrect responses to the MMSE by glu- 
cose tolerance status: the Zutphen Elderly Study, 1990 
Normal IGT New diabetes Known diabetes 
(n = 340) (n = 47) (n = 38) (n = 37) 
Characteristics p -value a
Age (years) 
Manual occupation (%) 
Presence of stroke (%) 
Area under the insulin curve 
(pmol. 1-1. min -1) 
MMSE score <_ 25 (%) 
Number of incorrect responses on 
the MMSE b 
74.8 + 4.5 77.0 + 5.1 73.7 + 4.2 75.8 + 4.8 0.01 
26 19 16 27 0.41 
3 13 5 3 0.02 
37 274 + 16 696 50 799 + 21095 38 020 + 23 764 - 0.0001 
28 41 37 52 0.02 
3.7 + 2.7 4.7 + 3.2 4.0 + 2.8 4.9 + 2.9 0.01 
Rate ratios p-trend 
Unadjusted 1.00 1.26 1.08 1.31 0.01 
(1.02-1.55) (0.86-1.36) (1.07-1.60) 
Adjusted c 1.00 1.18 1.16 1.23 0.01 
(0.98-1.41) (0.91-1.48) (1.04-1.46) 
Data given as mean + SD. IGT, Impaired glucose tolerance ber of incorrect responses, c Adjusted for age, occupation and 
a Kruskall-Wallis test for continuous variables and chi-square cigarette smoking 
test for categorical variables, b MMSE score = 30 - mean num- 
Table 3. Selected characteristics and RRs (95 % confidence interval) of the number of incorrect responses to the MMSE by the 
level of area under the insulin curve in non-diabetic men: the Zutphen Elderly Study, 1990 
Quartiles of area under the insulin curve a
First Second Third Fourth 
(n = 97) (n = 96) (n = 96) (n = 97) 
Characteristics p-value b
Fasting insulin (pmol/1) 42.5 + 11.7 58.9 + 16.5 71.8 + 21.5 96.9 + 38.8 - 
1-h post-load insulin (pmol/1) 239.6 + 65.1 373.1 + 54.9 512.3 + 78.9 761.3 + 183.7 - 
2-h post-load insulin (pmol/1) 150.7 + 70.5 221.7 + 85.4 307.8 + 113.4 491.5 + 233.2 - 
Age (years) 74.8 + 4.8 75.3 + 4.7 75.0 + 4.3 75.1 + 4.6 0.81 
Manual occupation (%) 27 25 24 25 0.95 
Presence of stroke (%) 4 4 3 5 0.93 
MMSE score _< 25 (%) 24 27 30 40 0.1 
Number of incorrect responses 
on the MMSE ~ 3.5 + 2.8 3.8 + 2.6 3.7 + 2.7 4.5 + 2.8 0.01 
Rate ratios p-trend 
Unadjusted 1.00 1.08 1.06 1.29 0.02 
(0.88-1.33) (0.85-1.31) (1.08-1.57) 
Adjusted  1.00 1.06 1.05 1.25 0.02 
(0.87-1.29) (0.85-1.30) (1.04-1.50) 
Data given as mean + SD. 
a First quartile: area under the insulin curve (pmol. 1-1- min -1) 
<_ 26347, second quartile: > 26347 to 35660, third quartile: 
> 35660 to 48065, fourth quartile: >48065. b Kruskall-Wallis 
test for continuous variables and chi-square test for categorical 
variables, c MMSE score = 30 - mean number of incorrect 
responses, dAdjusted for age, occupation and cigarette smok- 
ing 
n i f icant  in teract ions  between age and  levels  of  glu- 
cose to le rance  (p > 0.1). 
When the ana lyses  were  conf ined  to known and 
newly -d iagnosed  iabet ic  pat ients  (n = 75) only, fast-  
ing g lucose  concent ra t ion  was pos i t ive ly  assoc ia ted  
wi th  the  number  of  e r roneous  answers  on  the  
MMSE.  Med ian  fast ing g lucose  concent ra t ion  of  the  
sub jects  w i th  d iabetes  was 8 .0mmol /1  (10th cen-  
ti le:6.3 mmol/1,  90th cent i le :12.4 mmol/1).  For  each  in- 
c rease  of  2 mmol/1 sub jects  made 5 % more  er rors  in 
the  MMSE,  a f ter  ad jus tment  for  age and  occupat ion  
(RR= 1.05, 95% CI :0.98-1.19) .  E ight  of  the  37 
1100 
known diabetic patients were using insulin. Their 
mean age at clinical diagnosis of diabetes was 
61.5 years (range 40-84 years). Exclusion of these 
eight patients did not change the results. 
Cognitive function and hyperinsulinaernia. Among 
the 386 non-diabetic subjects age, occupation, and 
presence of stroke was comparable across the quar- 
tiles of the area under the insulin curve (Table 3). 
The percentage with poor cognitive function 
(MMSE score < 23) as well as the percentage with 
borderline cognitive function (MMSE score 24-25) 
increased from the lowest to the highest quartile of 
the area under the insulin curve. The mean MMSE 
score decreased from 26.5 in the lowest quartile to 
25.5 in the highest quartile (p = 0.01). After adjust- 
ment for possible confounding effects of age, occupa- 
tion and cigarette smoking, the subjects in the highest 
insulin quartile gave 25 % more erroneous answers 
on the MMSE items compared with subjects in the 
lowest quartile (Table 3). Adjustment for potentially 
mediating factors, including cardiovascular diseases 
and factors associated with the insulin resistance syn- 
drome, did not change the coefficient. Analyses 
pointed to a possible interaction between age and in- 
sulin quartiles (2 = 0,09), suggesting that the associa- 
tion between hyperinsulinaemia and cognitive im- 
pairment was stronger in the older ( > 75 years) than 
in the younger ( < 75 years) age group. Subjects old- 
er than 75 years in the highest insulin quartile made 
45 % more errors in the MMSE compared with those 
in the lowest quartile after adjustment for potential 
confounders (RR = 1.45, 95 % CI: 1.14-1.85). Cogni- 
tive impairment was more strongly associated with 
the area under the insulin curve than with the fasting 
oi" post-load insulin concentrations. Comparing the 
highest o the lowest quartiles of hourly insulin mea- 
sures, the rate ratio for 1-h and 2-h insulin concentra- 
tions was 1.16 (95 % CI:0.96-1.39) and 1.11 (95 % 
CI:0.92-1.33), respectively. The lowest rate ratio was 
found for the fasting insulin concentrations 
(RR = 1.08, 95 % CI:0.89-1.32). 
The glucose tolerance and hyperinsulinaemia re-
sults were essentially the same when subjects with 
stroke were excluded from the analyses (results not 
shown). Additional adjustment for fasting insulin in 
the analysis on glucose tolerance did not change the 
results (p-trend = 0.01), neither did adjustment for 
glucose tolerance in the analyses on hyperinsulin- 
aemia (p-trend = 0.02). In the joint analysis in non-di- 
abetic subjects with the 2-h glucose and the area un- 
der the insulin curve as continuous measures, the 
rate ratio for 2-h glucose was 1.01 per mmol/1 (95 % 
CI: 0.97-1.05) and 1.04 per 10 nmol/1 -a 9 min -1 (95 % 
CI: 1.00-1.07) for the area under the insulin curve. 
These rate ratios were not different from those ob- 
tained when each variable was entered separately in 
the model. There were no significant interactions be- 
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tween levels of glucose tolerance and insulin quar- 
tiles (p > 0.1), indicating that the relationship be- 
tween glucose tolerance and cognitive function did 
not vary across the quartiles of area under the insulin 
curve and vice versa. 
Discussion 
We found that non-diabetic subjects with impaired 
glucose tolerance and hyperinsulinaemia h d im- 
paired cognitive function as measured by the 
MMSE. Among diabetic patients cognitive function 
was even more impaired and decreased with increas- 
ing concentrations of fasting plasma glucose, which 
is an index of short-term glycaemic ontrol. These re- 
sults could not be explained by differences in age, oc- 
cupation or smoking behaviour. Nor were they al- 
tered when subjects with stroke or diabetic patients 
using insulin were excluded. Joint analysis showed 
that hyperinsulinaemia w s related to cognitive im- 
pairment, independent ofglucose tolerance. Further- 
more, diabetes and impaired glucose tolerance were 
related to cognitive impairment, independent of fast- 
ing insulin. Among non-diabetic subjects, the rela- 
tionship of cognitive function to 2-h glucose and 
area under the insulin curve did not change when 
both glucose levels and area under the insulin curve 
were entered into the model. 
There are a few methodological issues that should 
be taken into account when interpreting our results. 
First, as our study was cross-sectional, caution is 
needed regarding the direction of causality. Possibly, 
severe cognitive impairment leads to a deterioration 
of glycaemic ontrol in diabetic patients. It is how- 
ever not likely that cognitive impairment leads to glu- 
cose intolerance (i.e. diabetes or impaired glucose 
tolerance) or hyperinsulinaemia. Furthermore, selec- 
tive non-response or survival may have affected the 
validity of this study. In another study, cognitive im- 
pairment and diabetes were shown to be more fre- 
quent in non-responders than responders [23]. It is 
also possible that subjects in whom diabetes and cog- 
nitive impairment are both present, have relatively 
higher mortality rates. If these selection biases apply 
to our study, it would probably result in an underesti- 
mation of the association between cognitive impair- 
ment and glucose intolerance or hyperinsulinaemia. 
We used the area under the insulin curve as an indica- 
tor of hyperinsulinaemia, r ther than a single mea- 
surement of insulin. This area under the curve was a 
better predictor of cognitive function. This might be 
so because the within-subject variation of the area 
under the insulin curve is smaller than that of the 
hourly insulin measures [24]. Finally, serum insulin 
was measured with a conventional immunoassay, 
which is known to cross-react with proinsulin. Al- 
though proinsulin is known to be increased in diabe- 
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tes and impaired glucose tolerance, it constitutes only 
a minor part of the total insulin measured [25] and is 
therefore probably not responsible for the observed 
association with cognitive function. 
Our findings of impaired cognitive function in dia- 
betic patients agree with earlier clinical studies how- 
ing first, that elderly patients with non-insulin-depen- 
dent diabetes mellitus (NIDDM) had poorer cogni- 
tive function compared with normal control subjects 
[6-8, 26], and secondly, that increasing levels of 
glycated haemoglobin N IDDM patients were asso- 
ciated with poorer performance [6, 7]. Meneilly et al. 
[26] showed that improvement of glycaemic ontrol 
in patients with N IDDM increased selected aspects 
of cognition. In contrast, a longitudinal study found 
no significant relationship between N IDDM and cog- 
nitive impairment [27]. However, the subjects with 
N IDDM were young and had a high level of formal 
education. U'ren et al. [8] found that subjects not 
known to have diabetes, but who had raised glycated 
haemoglobin levels ( > 10 %), showed levels of cogni- 
tive performance intermediate between normal and 
diabetic subjects. This study is consistent with our 
finding that subjects with impaired glucose tolerance 
performed more poorly on the cognitive test com- 
pared to normoglycaemic subjects. Our finding of an 
association between hyperinsulinaemia and cogni- 
tive impairment is consistent with that of Kuusisto 
et al. [9], who found that hyperinsulinaemia identi- 
fied a subgroup of hypertensive subjects with particu- 
larly impaired cognition. 
We examined some potential explanatory mecha- 
nisms for the relation between glucose intolerance, 
hyperinsulinaemia and cognitive function. First, we 
investigated risk factors associated with the insulin 
resistance syndrome (hypertension, obesity, de- 
creased HDL cholesterol, increased triglyceride con- 
centrations and increased fibrinogen) [2-4] as medi- 
ating factors. The inclusion of these factors did not al- 
ter the results. Second, our adjustment for cardiovas- 
cular disease, as clinical manifestations of atheroscle- 
rosis, did not change the outcome. Moreover, exclu- 
sion of subjects with stroke did not alter the results. 
There is substantial evidence that glucose intoler- 
ance and hyperinsulinaemia are associated with ath- 
erosclerosis, thrombosis and hypertension [1, 4, 28], 
all of which may lead to cognitive impairment 
through cerebral infarcts or white matter disease [5]. 
Since atherosclerosis was not directly measured and 
we had no information on the severity of the cardio- 
vascular disease, we cannot exclude this process as a 
mechanism explaining the association between glu- 
cose intolerance, hyperinsulinaemia and cognitive 
impairment. Furthermore, other mechanisms may be 
responsible for the poorer cognitive function in sub- 
jects with glucose intolerance and hyperinsulin- 
aemia. The cognitive impairment of diabetic patients 
may be due to hypoglycaemia [29], increased free 
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radical generation [30], or the same axonal damage 
as occurs in peripheral neuropathy [31]. Hyperinsu- 
linaemia might affect cognitive function through vas- 
cular processes regulated by the sympathetic ner- 
vous system [32] or by influencing synaptic activity 
in the brain [33]. In future studies, information on 
the degree of atherosclerosis, the presence of cere- 
bral infarcts or white matter disease, and the activity 
of the sympathetic nervous system, by measurement 
of plasma norepinephrine, would help to clarify the 
mechanisms through which insulin can affect cogni- 
tive function. Also important is to test aspects of cog- 
nitive function not measured by the MMSE, but that 
can be affected in diabetes, such as complex psycho- 
motor function [34]. Further studies may also help to 
explain why dose-response was not strong and why 
the association between insulin and cognition varied 
with age. 
In conclusion, cognitive function might not only be 
impaired in diabetic patients, but also in elderly sub- 
jects with impaired glucose tolerance and hyperinsu- 
linaemia. In addition, poorer glycaemic ontrol was 
associated with poorer cognitive function in diabetic 
patients. Clinicians should be alert to the possibility 
that patients with diabetes, impaired glucose toler- 
ance or hyperinsulinaemia may be at risk for cogni- 
tive impairment. 
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